RSSS
Published on 05/08/2025 at 16:07
Reports 23 Percent Increase in ARR to $20.4 Million and 43 Net New Platform Deployments, Positive Net Income and Record Adjusted EBITDA and Cashflow
HENDERSON, Nev., May 8, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal third quarter ended March 31, 2025.
Fiscal Third Quarter 2025 Summary
"This quarter represents a number of significant milestone achievements for our Company. We are pleased to report ARR above $20 million for the first time in our history. Revenue from our AI-based B2B offerings has grown over 180% in the last year, and we continue to experience strong growth in our B2C offerings and core Article Galaxy platform. These results are due in part to our revamped sales strategy, which better demonstrates to potential customers the improved efficiency and cost savings offered by our products within the research process workflow," said Roy W. Olivier, President and CEO of Research Solutions. "As we experience strong organic growth in ARR sales, we continue to outperform when it comes to generating operating cash flow and Adjusted EBITDA, which positions us to reinvest in our business or make acquisitions that broaden our product capabilities and enhance our cross-selling opportunities."
Fiscal Third Quarter 2025 Results
Total revenue was $12.7 million, a 4.5% increase from $12.1 million in the year-ago quarter as platform revenue growth more than offset a decline in transaction revenue from the prior period.
Platform subscription revenue increased 22% to $4.8 million compared to $4.0 million in the year-ago quarter. The increase was primarily due to an increase in the total number of paid Platform deployments and B2C subscribers, as well as upsells to existing customers. The quarter ended with annual recurring revenue of $20.4 million, up 23% year-over-year (see the Company's definition of annual recurring revenue below).
Transaction revenue was $7.8 million, compared to $8.2 million in the third quarter of fiscal 2024. The decrease was primarily due to lower paid order volume in the period. The transaction customer count for the quarter was 1,380, compared to 1,426 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).
Total gross margin improved 430 basis points from the prior-year quarter to 49.5%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platforms business as well as increased margins in that business and the transaction business.
Total operating expenses were $5.7 million, compared to $5.4 million in the third quarter of 2024. The increases were related to additional costs in Sales and Marketing, offset by some reductions in General and Administrative expenses.
Net income for the third quarter was $216,000, or $0.01 per diluted share, compared to net income of $76,000, or nil per diluted share, in the prior-year quarter. Adjusted EBITDA was $1.4 million, compared to $961,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).
Conference Call
Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.
Date: Thursday, May 8, 2025Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-518-9843Conference ID: RESEARCH
The conference call will be broadcast live and available for replay until June 8, 2025 by dialing 1-412-317-6671 and using the replay ID 11158769, and via the investor relations section of the company's website at http://researchsolutions.investorroom.com/.
Fiscal Third Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
Quarter Ended March 31,
Nine Months Ended March 31,
2025
2024
Change
% Change
2025
2024
Change
% Change
Revenue:
Platforms
$ 4,839,929
$ 3,953,403
$ 886,526
22.4 %
$ 13,770,831
$ 9,679,179
$ 4,091,652
42.3 %
Transactions
$ 7,821,434
$ 8,162,269
(340,835)
-4.2 %
$ 22,849,233
$ 22,811,206
38,027
0.2 %
Total Revenue
12,661,363
12,115,672
545,691
4.5 %
36,620,064
32,490,385
4,129,679
12.7 %
Gross Profit:
Platforms
4,229,623
3,382,051
847,572
25.1 %
11,993,516
8,239,028
3,754,488
45.6 %
Transactions
2,037,457
2,099,881
(62,424)
-3.0 %
5,860,533
5,758,272
102,261
1.8 %
Total Gross Profit
6,267,080
5,481,932
785,148
14.3 %
17,854,049
13,997,300
3,856,749
27.6 %
Gross profit as a % of revenue:
Platforms
87.4 %
85.5 %
1.8 %
87.1 %
85.1 %
2.0 %
Transactions
26.0 %
25.7 %
0.3 %
25.6 %
25.2 %
0.4 %
Total Gross Profit
49.5 %
45.2 %
4.3 %
48.8 %
43.1 %
5.7 %
Operating Expenses:
Sales and marketing
1,607,678
1,122,365
485,313
43.2 %
4,141,172
2,612,308
1,528,864
58.5 %
Technology and product development
1,394,936
1,371,754
23,182
1.7 %
4,274,543
3,952,891
321,652
8.1 %
General and administrative
1,845,411
2,027,074
(181,663)
-9.0 %
5,783,788
6,593,791
(810,002)
-12.3 %
Depreciation and amortization
312,013
309,898
2,115
0.7 %
930,341
525,267
405,074
77.1 %
Stock-based compensation
594,639
541,002
53,637
9.9 %
1,546,950
1,729,271
(182,321)
-10.5 %
Foreign currency translation loss
(44,519)
22,177
(66,696)
NM
(119,205)
15,059
(134,264)
NM
Total Operating Expenses
5,710,158
5,394,270
315,888
5.9 %
16,557,589
15,428,587
1,129,003
7.3 %
Income (loss) from operations
556,922
87,663
469,259
535.3 %
1,296,460
(1,431,286)
2,727,746
NM
Other Income (Expenses):
Other income
(327,042)
31,228
(358,270)
NM
(2,316,404)
547,965
(2,864,369)
NM
Provision for income taxes
(13,410)
(42,590)
29,180
-68.5 %
(74,816)
(82,049)
7,233
-8.8 %
Total Other Income (Expenses):
(340,452)
(11,362)
(329,090)
NM
(2,391,220)
465,916
(2,857,136)
NM
Net income (loss)
$ 216,470
$ 76,301
140,169
183.7 %
$ (1,094,760)
$ (965,370)
(129,390)
-13.4 %
NM
Adjusted EBITDA
$ 1,419,055
$ 960,740
$ 458,315
47.7 %
$ 3,654,546
$ 838,311
$ 2,816,235
335.9 %
Quarter Ended March 31,
Nine Months Ended March 31,
2025
2024
Change
% Change
2025
2024
Change
% Change
Platforms:
B2B ARR (Annual recurring revenue*):
Beginning of Period
$ 12,738,256
$ 11,614,748
$ 1,123,508
9.7 %
$ 12,060,201
$ 9,444,130
$ 2,616,071
27.7 %
Incremental ARR
735,818
38,315
697,503
1820.4 %
1,413,873
2,208,933
(795,060)
-36.0 %
End of Period
$ 13,474,074
$ 11,653,063
$ 1,821,011
15.6 %
$ 13,474,074
$ 11,653,063
$ 1,821,012
15.6 %
Deployments:
Beginning of Period
1,090
942
148
15.7 %
1,021
835
186
22.3 %
Incremental Deployments
43
41
2
4.9 %
112
148
(36)
-24.3 %
End of Period
1,133
983
150
15.3 %
1,133
983
150
15.3 %
ASP (Average sales price):
Beginning of Period
$ 11,686
$ 12,330
$ (643)
-5.2 %
$ 11,812
$ 11,310
$ 502
4.4 %
End of Period
$ 11,892
$ 11,855
$ 38
0.3 %
$ 11,892
$ 11,855
$ 38
0.3 %
B2C ARR (Annual recurring revenue*):
Beginning of Period
$ 6,371,381
$ 3,954,090
$ 2,417,291
61.1 %
$ 5,363,129
$ -
$ 5,363,129
NM
Incremental ARR
506,545
948,885
(442,340)
NM
1,514,797
4,902,975
(3,388,178)
NM
End of Period
$ 6,877,926
$ 4,902,975
$ 1,974,951
40.3 %
$ 6,877,926
$ 4,902,975
$ 1,974,951
40.3 %
Total ARR (Annualized recurring revenue):
$ 20,352,000
$ 16,556,038
$ 3,795,962
22.9 %
$ 20,352,000
$ 16,556,038
$ 3,795,963
22.9 %
Transaction Customers:
Corporate customers
1,060
1,105
(45)
-4.1 %
1,062
1,087
(25)
-2.3 %
Academic customers
320
321
(1)
-0.3 %
323
320
3
1.0 %
Total customers
1,380
1,426
(46)
-3.2 %
1,385
1,407
(22)
-1.5 %
Active Customer Accounts, Transactions and Annual Recurring Revenue
The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense) including any change in fair value of contingent earnout liability, foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
Quarter Ended March 31,
Nine Months Ended March 31,
2025
2024
Change
% Change
2025
2024
Change
% Change
Net Income (loss)
$ 216,470
$ 76,301
$ 140,169
183.7 %
$ (1,094,760)
$ (965,370)
$ (129,390)
-13.4 %
Add (deduct):
-
Other (income) expense
327,042
(31,228)
358,270
NM
2,316,404
(547,965)
2,864,369
NM
Foreign currency translation loss (gain)
(44,519)
22,177
(66,696)
NM
(119,205)
15,059
(134,264)
NM
Provision for income taxes
13,410
42,590
(29,180)
-68.5 %
74,816
82,049
(7,233)
-8.8 %
Depreciation and amortization
312,013
309,898
2,115
0.7 %
930,341
525,267
405,074
77.1 %
Stock-based compensation
594,639
541,002
53,637
9.9 %
1,546,950
1,729,271
(182,321)
-10.5 %
Adjusted EBITDA
$ 1,419,055
$ 960,740
$ 458,315
47.7 %
$ 3,654,546
$ 838,311
$ 2,816,235
335.9 %
About Research SolutionsResearch Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the Company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the Company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visit www.researchsolutions.com
Important Cautions Regarding Forward-Looking StatementsCertain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
March 31,
June 30,
2025
2024
Assets
Current assets:
Cash and cash equivalents
$
9,852,007
$
6,100,031
Accounts receivable, net of allowance of $82,026 and $68,579, respectively
7,604,058
6,879,800
Prepaid expenses and other current assets
625,727
643,553
Prepaid royalties
755,299
1,067,237
Total current assets
18,837,091
14,690,621
Non-current assets:
Property and equipment, net of accumulated depreciation of $944,694 and $922,558, respectively
60,051
88,011
Intangible assets, net of accumulated amortization of $2,431,738 and $1,535,310, respectively
9,956,378
10,764,261
Goodwill
16,372,979
16,315,888
Deposits and other assets
881
981
Total assets
$
45,227,380
$
41,859,762
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses
$
8,529,572
$
8,843,612
Deferred revenue
10,355,768
9,023,848
Contingent earnout liability, current portion
6,019,488
—
Total current liabilities
24,904,828
17,867,460
Non-current liabilities:
Contingent earnout liability, long-term portion
9,091,422
12,298,114
Total liabilities
33,996,250
30,165,574
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding
—
—
Common stock; $0.001 par value; 100,000,000 shares authorized; 32,405,120 and 32,295,373 shares issued and outstanding, respectively
32,405
32,295
Additional paid-in capital
38,728,405
38,089,958
Accumulated deficit
(27,404,006)
(26,309,246)
Accumulated other comprehensive loss
(125,674)
(118,819)
Total stockholders' equity
11,231,130
11,694,188
Total liabilities and stockholders' equity
$
45,227,380
$
41,859,762
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(Unaudited)
Three Months Ended
Nine Months Ended
March 31,
March 31,
2025
2024
2025
2024
Revenue:
Platforms
$
4,839,929
$
3,953,403
$
13,770,831
$
9,679,179
Transactions
7,821,434
8,162,269
22,849,233
22,811,206
Total revenue
12,661,363
12,115,672
36,620,064
32,490,385
Cost of revenue:
Platforms
610,306
571,352
1,777,315
1,440,151
Transactions
5,783,977
6,062,388
16,988,700
17,052,934
Total cost of revenue
6,394,283
6,633,740
18,766,015
18,493,085
Gross profit
6,267,080
5,481,932
17,854,049
13,997,300
Operating expenses:
Selling, general and administrative
5,398,145
5,084,371
15,627,248
14,903,319
Depreciation and amortization
312,013
309,898
930,341
525,267
Total operating expenses
5,710,158
5,394,269
16,557,589
15,428,586
Income (loss) from operations
556,922
87,663
1,296,460
(1,431,286)
Other income
78,868
31,228
496,392
279,678
Change in fair value of contingent earnout liability
(405,910)
—
(2,812,796)
268,287
Income (loss) before provision for income taxes
229,880
118,891
(1,019,944)
(883,321)
Provision for income taxes
(13,410)
(42,590)
(74,816)
(82,049)
Net income (loss)
216,470
76,301
(1,094,760)
(965,370)
Other comprehensive income (loss):
Foreign currency translation
(3,324)
858
(6,855)
6,261
Comprehensive income (loss)
$
213,146
$
77,159
$
(1,101,615)
$
(959,109)
Basic income (loss) per common share:
Net income (loss) per share
$
0.01
$
-
$
(0.04)
$
(0.03)
Weighted average common shares outstanding
31,033,022
30,020,652
30,597,410
28,377,199
Diluted income (loss) per common share:
Net income (loss) per share
$
0.01
$
-
$
(0.04)
$
(0.03)
Weighted average common shares outstanding
32,139,935
33,511,242
30,597,410
28,377,199
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended
March 31,
2025
2024
Cash flow from operating activities:
Net loss
$
(1,094,760)
$
(965,370)
Adjustment to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
930,341
525,267
Stock options expense
146,751
104,502
Restricted common stock expense
1,400,199
1,603,820
Modification cost of accelerated vesting of restricted common stock
—
20,949
Adjustment to contingent earnout liability
2,812,796
(268,287)
Changes in operating assets and liabilities:
Accounts receivable
(754,258)
(739,883)
Prepaid expenses and other current assets
17,826
(156,026)
Prepaid royalties
311,938
197,888
Accounts payable and accrued expenses
(338,502)
498,584
Deferred revenue
1,331,920
768,347
Net cash provided by operating activities
4,764,251
1,589,791
Cash flow from investing activities:
Purchase of property and equipment
(11,571)
(57,761)
Payment for acquisition of Resolute, net of cash acquired
—
(2,718,253)
Payment for acquisition of Scite, net of cash acquired
—
(7,305,493)
Net cash used in investing activities
(11,571)
(10,081,507)
Cash flow from financing activities:
Common stock repurchase
(908,393)
(522,024)
Payment of contingent acquisition consideration
(91,174)
(314,960)
Net cash used in financing activities
(999,567)
(836,984)
Effect of exchange rate changes
(1,137)
4,791
Net increase (decrease) in cash and cash equivalents
3,751,976
(9,323,909)
Cash and cash equivalents, beginning of period
6,100,031
13,545,333
Cash and cash equivalents, end of period
$
9,852,007
$
4,221,424
Supplemental disclosures of cash flow information:
Cash paid for income taxes
$
74,816
$
82,049
Non-cash investing and financing activities:
Contingent consideration accrual on asset acquisition
$
29,394
$
36,130
View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-fiscal-third-quarter-2025-results-302450491.html
SOURCE Research Solutions, Inc.